These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17087855)

  • 1. Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism.
    Peterson LR
    Curr Hypertens Rep; 2006 Dec; 8(6):451-6. PubMed ID: 17087855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and Cardiac Remodeling in Adults: Mechanisms and Clinical Implications.
    Alpert MA; Karthikeyan K; Abdullah O; Ghadban R
    Prog Cardiovasc Dis; 2018; 61(2):114-123. PubMed ID: 29990533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial metabolism and cardiac performance in obesity and insulin resistance.
    Banerjee S; Peterson LR
    Curr Cardiol Rep; 2007 Apr; 9(2):143-9. PubMed ID: 17430682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity cardiomyopathy: pathogenesis and pathophysiology.
    Wong C; Marwick TH
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):436-43. PubMed ID: 17653116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial steatosis, cardiac remodelling and fitness in insulin-sensitive and insulin-resistant obese women.
    Utz W; Engeli S; Haufe S; Kast P; Hermsdorf M; Wiesner S; Pofahl M; Traber J; Luft FC; Boschmann M; Schulz-Menger J; Jordan J
    Heart; 2011 Oct; 97(19):1585-9. PubMed ID: 21775510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity Cardiomyopathy: Pathophysiologic Factors and Nosologic Reevaluation.
    Bhatheja S; Panchal HB; Ventura H; Paul TK
    Am J Med Sci; 2016 Aug; 352(2):219-22. PubMed ID: 27524223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women.
    Peterson LR; Herrero P; Schechtman KB; Racette SB; Waggoner AD; Kisrieva-Ware Z; Dence C; Klein S; Marsala J; Meyer T; Gropler RJ
    Circulation; 2004 May; 109(18):2191-6. PubMed ID: 15123530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leptin as a mediator between obesity and cardiac dysfunction].
    Karbowska J; Kochan Z
    Postepy Hig Med Dosw (Online); 2012 May; 66():267-74. PubMed ID: 22706112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.
    Alpert MA; Omran J; Bostick BP
    Curr Obes Rep; 2016 Dec; 5(4):424-434. PubMed ID: 27744513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial insulin resistance and cardiac complications of diabetes.
    Abel ED
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):219-26. PubMed ID: 16089356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tipping the balance: the pathophysiology of obesity and type 2 diabetes mellitus.
    McKenney RL; Short DK
    Surg Clin North Am; 2011 Dec; 91(6):1139-48, vii. PubMed ID: 22054144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic remodelling in human heart failure.
    Tuunanen H; Knuuti J
    Cardiovasc Res; 2011 May; 90(2):251-7. PubMed ID: 21372005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Signaling and Heart Failure.
    Riehle C; Abel ED
    Circ Res; 2016 Apr; 118(7):1151-69. PubMed ID: 27034277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance.
    Wensley I; Salaveria K; Bulmer AC; Donner DG; du Toit EF
    Exp Physiol; 2013 Nov; 98(11):1552-64. PubMed ID: 23851919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin signaling in the heart.
    Abel ED
    Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E130-E145. PubMed ID: 34056923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of reduced preclinical left ventricular diastolic function and cardiac remodeling in overweight youth to insulin resistance and inflammation.
    Dahiya R; Shultz SP; Dahiya A; Fu J; Flatley C; Duncan D; Cardinal J; Kostner KM; Byrne NM; Hills AP; Harris M; Conwell LS; Leong GM
    Am J Cardiol; 2015 May; 115(9):1222-8. PubMed ID: 25765589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the insulin resistance syndrome the price to be paid to achieve body weight stability?
    Tremblay A; Boulé N; Doucet E; Woods SC
    Int J Obes (Lond); 2005 Oct; 29(10):1295-8. PubMed ID: 15997249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac adaptations to obesity, diabetes and insulin resistance.
    Glatz JFC; Dyck JRB; Des Rosiers C
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1905-1907. PubMed ID: 29391209
    [No Abstract]   [Full Text] [Related]  

  • 20. Obesity cardiomyopathy: is it a reality? An ultrasonic tissue characterization study.
    Di Bello V; Santini F; Di Cori A; Pucci A; Palagi C; Delle Donne MG; Fierabracci P; Marsili A; Talini E; Giannetti M; Biadi O; Balbarini A; Mariani M; Pinchera A
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1063-71. PubMed ID: 16880104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.